DIFFERENTIAL DNA METHYLATION OF NK CELLS PREVENTS THEIR EXCESSIVE ACTIVATION

Background and Objectives: Epigenetic mechanisms, particularly DNA methylation, represent a key regulatory layer governing immune cell differentiation, lineage commitment, and functional adaptation. Progressive alterations in DNA methylation accompany immune cell maturation and contribute to the emergence of specialized immune subsets. Although several lineage-specific methylation signatures have been identified, the broader role of DNA methylation in regulating immune activation remains incompletely defined. This study aimed to summarize current evidence on how DNA methylation shapes immune cell identity and modulates activation dynamics, with particular emphasis on regulatory T cells and natural killer (NK) cells.
Methods: Evidence from recent epigenomic and immunological studies was examined to characterize methylation patterns associated with immune cell differentiation and activation. Particular attention was given to studies identifying differentially methylated regions in key regulatory loci and genes involved in immune signaling pathways.
Results: DNA methylation patterns were found to correlate strongly with immune cell lineage specification and functional states. Demethylation of the FOXP3 locus represents a hallmark epigenetic signature of CD4⁺ regulatory T cells and is essential for their stable differentiation and maintenance of immune tolerance. Similarly, reduced methylation at CpG sites within the NCR1/NKp46 locus is significantly associated with NK cell abundance and spatial distribution. In activated NK cells, multiple differentially methylated regions have been identified in genes involved in inflammatory regulation. Notably, altered methylation states of IL1RN, ECE1, CSF2, and DCHS1 were significantly associated with transcriptional repression during activation (reported p < 0.05 in the referenced studies), suggesting a regulatory mechanism that constrains excessive inflammatory responses.
Conclusion: DNA methylation plays a central role in orchestrating immune cell differentiation and modulating activation responses. Specific methylation signatures, such as those observed in FOXP3 and NCR1, serve as robust biomarkers of immune cell identity, while dynamic methylation changes in genes including IL1RN, ECE1, CSF2, and DCHS1 contribute to the fine-tuning of NK cell activity. A deeper understanding of these epigenetic mechanisms may support the development of targeted therapeutic strategies aimed at modulating immune responses while preserving immune homeostasis.